Research Article

Supportive Care Needs following Cancer Treatment: A Comparison of Breast and Brain Cancer in an Australian Cohort

Table 1

Sociodemographic characteristics of participants ( ).

, (%) (unless otherwise stated)
Breast cancer
( )
Brain tumour
( )

Demographic factors
Age (years)
 (Mean (SD), range)57.6 (10.6), 34.8–81.852.6 (13.6), 22.1–78.5
Sex
 Female85 (100)61 (57.5)
Marital status
 Married/partner53 (62.4)81 (76.4)
Living with
 Partner/family68 (80.0)81 (76.4)
Education
 Secondary37 (43.5%)55 (51.9)
 Tertiary43 (50.6%)47 (44.3)
Smokers13 (15.3%)17 (16.0)
Consumes alcohol46 (54.1%)45 (42.5)
Clinical characteristics
Disease duration (years)
(Md, (IQR))2.2 (1.4–4.9)2.1 (0.8, 4.0)
Tumour gradingBRE* ( )WHO** ( )
 Grade 1 10 (12.0%)14 (14.6)
 Grade 2 28 (33.7%)30 (31.3)
 Grade 3 45 (54.2%)15 (15.6)
 Grade 4N/A37 (38.5)
Surgery85 (100%)105 (99.1)
 ≥2 surgery episodes36 (42.4%)33 (31.4)
Chemotherapy63 (74.1%)45 (42.5)
 Multiple episode54 (96.4%)19 (42.2)
 Side effects60 (70.6%)31 (68.9)
Radiotherapy63 (74.1%)68 (64.2)
 Multiple episode48 (76.2%)44 (64.7)
 Side effects47 (55.3%)45 (66.2)
Currently on treatment 55 (64.7%)
Comorbidities
 Hypertension27 (31.8%)30 (28.3)
 Diabetes5 (5.9%)5 (4.7)
 Depression28 (32.9%)12 (11.3)
 Pain63 (74.1%)59 (55.7)
 VAS pain score (0: no pain; 10: extreme pain)
  Mean (SD), range3.8 (2.1), 1–83.0 (2.0, 5.0)

IQR: interquartile range, Md: median, : total number, SD: standard deviation, VAS: visual analogue scale.
*BRE: Bloom-Richardson-Elston grading.
**WHO: World Health Organisation classification of brain tumours (gliomas).